Amgen Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AMG.F | BIIB | NVS | BMY | REC.MI | SOBI.ST | |
|---|---|---|---|---|---|---|
| Market cap | 210.90B | 35.61B | 292.58B | 124.85B | 11.01B | 159.53B |
| P/E (TTM) | 28.3 | 42.8 | 23.3 | 13.5 | 22.2 | 119.4 |
| Forward P/E | — | 14.6 | 15.7 | 9.3 | 14.0 | 29.5 |
| Price/book | 20.2 | 1.9 | 7.0 | 5.6 | 5.1 | 3.8 |
| Dividend yield | 2.25% | — | 3.09% | 4.09% | 2.68% | — |
| 1-year change | +51.65% | +64.57% | +16.90% | +38.95% | +2.91% | +41.33% |
| Today | +1.04% | −0.87% | +0.19% | −0.91% | −0.09% | +2.64% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All AMG.F news ›AMGEN Inc
Set by 24/7 Wall St.’s proprietary analysis of professional targets, profit trajectory, sector, risk, and retail attention. How we calculate our price targets → Amgen appears attractively valued at current levels. With a 10.0% upside to…
Amgen, AstraZeneca's Tezspire achieves 69% remission in Phase III EoE trial
AllSci is an AI-grounded scientific knowledge platform. It aggregates the global scientific literature, patents, grants and trials, atomizes them into hypotheses, questions, results and claims, links everything to canonical entity…
Amgen and AstraZeneca report positive Phase III results for Tezspire in EoE
Tezspire improved swallowing symptoms and reduced oesophageal inflammation in patients with eosinophilic oesophagitis, with benefits sustained through 52 weeks, supporting its potential as a third indication AstraZeneca and Amgen have…
From Discovery to Delivery: 5 Ways Amgen Is Putting Sustainability into Practice
Across Amgen, teams are looking for ways to use resources efficiently, reduce costs, and improve environmental sustainability. Across research and development, packaging, transportation, and sourcing here are examples of how Amgen teams…
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Oct 20 (Reuters) – Amgen and AstraZeneca said on Tuesday their asthma drug helped reduce swallowing difficulties and achieved disease remission in 69% of patients with a type of chronic inflammatory disorder of the esophagus. The result…
Amgen (AMGN) Stock Is Up, What You Need To Know
Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that blocked a first-of-its-kind state price cap on its blockbuster drug, Enbrel. After the initial pop,…
Merck vs. Amgen: Which Dividend Stock Pays You More in 10 Years?
AtlasStudio from Getty Images via Canva On Aug. 4, Merck (MRK) raised and narrowed its 2026 sales outlook to $66.3 billion to $67.3 billion. The same day, Amgen (AMGN) reported second-quarter revenue up 10% to $10.1 billion. For income…
Amgen (AMGN): The Biotech Pioneer Preparing for Its Next Growth Wave
Initially, the pharmaceutical industry was built on the ability to identify, isolate, and purify chemical compounds with medicinal virtues, for example, how salicylic acid found in tree bark was turned into pure Aspirin, or antibiotics…
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Collegium Pharmaceutical (COLL)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN) and Collegium Pharmaceutical (COLL). In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Amgen,…
Amgen Inc. $AMGN Stock Bought by Sumitomo Mitsui DS Asset Management Company Ltd
Check Out Our Latest Research Report on AMGN The business also recently announced a quarterly dividend, which was paid on Friday, September 11th. Shareholders of record on Friday, August 21st were paid a $2.52 dividend. This represents a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketbeat.com21
-
marketscreener.com21
-
trefis.com6
-
gurufocus.com4
-
kalkinemedia.com4
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 104 articles, not a forecast.